Blog - INTERNET MÉDICA

■ Clinical presentation, epidemiology, neurophysiological findings, treatment and outcome of nonconvulsive status epilepticus: a 3-year prospective, hospital-based study

Boulenouar Mesraoua, Dirk Deleu, Hassan Al Hail, et al

J Drug Assess. 2017; 6(1): 18–32

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700530/

■ Protocolos de manejo de estado de mal epiléptico no pronto socorro pediátrico: análise sistemática

Au, Cheuk C., Branco, Ricardo G. and Tasker, Robert C.

Pediatr. (Rio J.), 2017, vol.93, suppl.1, p.84-94

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572017000700084&lng=en&nrm=iso&tlng=pt (portuguese)

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572017000700084&lng=en&nrm=iso&tlng=en (english)

■ Timing is everything: where status epilepticus treatment falls

Chloe E. Hill, Alomi O. Parikh, Colin Ellis, Jennifer S. Myers, Brian Litt

Ann Neurol. 2017 Aug; 82(2): 155–165

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823514/

■ Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society

Tracy Glauser, Shlomo Shinnar, David Gloss et al

Epilepsy Curr. 2016 Jan-Feb; 16(1): 48–61

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749120/

■ Neurophysiological and neuroimaging changes (crossed cerebrocerebellar atrophy) after prolonged non-convulsive status epilepticus

Sabatini, Jivago S. et al.

Arq. Neuro-Psiquiatr., Mar 2016, vol.74, no.3, p.256-257

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2016000300014&lng=en&nrm=iso

■ Management of status epilepticus in children

Douglas M. Smith, Emily L. McGinnis, Diana J. Walleigh, Nicholas S. Abend

J Clin Med. 2016 Apr; 5(4): 47

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850470/

■ Treatment of established status epilepticus

Jessica J. Falco-Walter, Thomas Bleck

J Clin Med. 2016 May; 5(5): 49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882478/

■ Pharmacotherapy for status epileptic

Eugen Trinka, Julia Höfler, Markus Leitinger, Francesco Brigo

Drugs. 2015; 75: 1499–1521

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/

■ Status epilepticus and beyond: A clinical review of status epilepticus and an update on current management strategies in super-refrractory status epilepticus

R Poblete, G Sung

Korean Journal of Critical Care Medicine 2017, vol 32 (2): 89-105

https://www.accjournal.org/journal/view.php?number=1088

■ Treatment of generalized convulsive status epilepticus in pediatric patients

Elizabeth L. Alford, James W. Wheless, Stephanie J. Phelps

J Pediatr Pharmacol Ther. 2015 Jul-Aug; 20(4): 260–289

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557718/

■ Status epilepticus and refractroy status epilepticus management

Nicholas S. Abend, David Bearden, Ingo Helbig et al

Semin Pediatr Neurol. 2014 Dec; 21(4): 263–274

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346709/

■ Refractory nonconvulsive status epilepticus in coma: analysis of the evolution of ictal patterns

Liberalesso, Paulo Breno Noronha et al.

Arq. Neuro-Psiquiatr., July 2012, vol.70, no.7, p.501-505

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2012000700006&lng=en&nrm=iso&tlng=en

■ Topiramate is effective for status epilepticus and seizure control in neuraminidase deficiency

Bragatti, José Augusto et al.

Arq. Neuro-Psiquiatr., June 2011, vol.69, no.3, p.565-566

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2011000400031&lng=en&nrm=iso

■ Estado de mal epiléptico em adultos: revisão e proposta de protocolo

Albuquerque, Milena de and Cendes, Fernando

epilepsy clin. neurophysiol., 2011, vol.17, no.4, p.164-175

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492011000400009&lng=en&nrm=iso

■ Estado de mal epiléptico

Garzon, Eliana.

epilepsy clin. neurophysiol., Nov 2008, vol.14, suppl.2, p.7-11

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492008000600002&lng=en&nrm=iso

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Novo endereço:

Consultório: Rua Padre Rolim 815/sala 815

Tel: 33245518 (Consulta Particular/Unimed)

– Centro Médico Unimed BH/Contagem/Pedro I

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com

Esclerose Múltipla: Artigos de Revisão Online (Multiple Sclerosis: Review)

Por Paulo Leite 26/05/2019

■ European and American guidelines or multiple sclerosis treatment

Angelo Ghezzi

Neurol Ther. 2018 Dec; 7(2): 189–194

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283786/

■ Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis

Marques, Vanessa Daccach et al.

Arq. Neuro-Psiquiatr., Aug 2018, vol.76, no.8, p.539-55

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000800539&lng=pt&nrm=iso&tlng=en

■ A systematic review and meta-analysis of the brief cognitive assessment for multiple sclerosis (BICAMS)

Freya Corfield, Dawn Langdon

Neurol Ther. 2018 Dec; 7(2): 287–306

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283796/

■ Recommendations for cognitive screening and management in multiple sclerosis care

Rosalind Kalb, Meghan Beier, Ralph HB Benedict, et al

Mult Scler. 2018 Nov; 24(13): 1665–1680.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238181/

■ Vitamin D and multiple sclerosis: a comprehensive review

Martina B. Sintzel, Mark Rametta, Anthony T. Reder

Neurol Ther. 2018 Jun; 7(1): 59–85

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990512/

■ Practical evidence-based recommendations for patients with multiple sclerosis who want to have children

Yara Dadalti Fragoso, Tarso Adoni, Joseph B. Bidin Brooks et al

Neurol Ther. 2018 Dec; 7(2): 207–232

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283793/

■ Basal cortisol levels and the relationship with clinical symptoms in multiple sclerosis: a systematic review

Pereira, Gabriela Magalhães et al.

Arq. Neuro-Psiquiatr., Sept 2018, vol.76, no.9, p.622-634

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000900622

■ Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study

Laisheng Cai, Jingwei Huang

Neuropsychiatr Dis Treat. 2018; 14: 2241–2254

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126505/

■ Repetitive transcranial magnetic stimulation, cognition, and multiple sclerosis: an overview

Grigorios Nasios, Lambros Messinis, Efthimios Dardiotis, Panagiotis Papathanasopoulos

Behav Neurol. 2018; 2018: 8584653

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822759/

■ Monitoring progressive multiple sclerosis with novel imaging techniques

Maria Petracca, Monica Margoni, Giulia Bommarito, Matilde Inglese

Neurol Ther. 2018 Dec; 7(2): 265–285

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283788/

■ Decision-making in multiple sclerosis patients: a systematic review

M Neuhaus, P Calabrese, J Annoni

Multiple Sclerosis International 2018, Article ID 7835952, 9 pages

https://www.hindawi.com/journals/msi/2018/7835952/

■ MRI in the assessment and monitoring of multiple sclerosis: an update on best practice

Ulrike W. Kaunzner, Susan A. Gauthier

Ther Adv Neurol Disord. 2017 Jun; 10(6): 247–261

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453402/

■ Current and emerging therapies in multiple sclerosis: implications for the radiologist, Part 1 – mechanisms, efficacy, and safetyurveillance for treatment complications and disease progression

McNamara, G. Sugrue, B. Murray and P.J. MacMahon

American Journal of Neuroradiology September 2017, vol 38 (9): 1664-1671

http://www.ajnr.org/content/ajnr/early/2017/04/13/ajnr.A5147.full.pdf

■ Current and emerging therapies in multiple sclerosis: implications for the radiologist, Part 2 – surveillance for treatment complications and disease progression

McNamara, G. Sugrue, B. Murray and P.J. MacMahon

American Journal of Neuroradiology September 2017, vol 38 (9): 1672-1680

http://www.ajnr.org/content/ajnr/38/9/1672.full.pdf

■ Multidisciplinary rehabilitation is efficacious and induces neural plasticity in multiple sclerosis even when complicated by progressive multifocal leuckoencephalopathy

Elisabetta Groppo, Francesca Baglio, Davide Cattaneo et al

Front Neurol. 2017; 8: 491

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610687/

■ Disease-modifying treatments for multiple sclerosis – a review of approved medications

Ø Torkildsen, K-M Myhr, L Bø

Eur J Neurol. 2016 Jan; 23(Suppl 1): 18–27

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670697/

■ Treatment strategies for multiple sclerosis: When to star, when to change, when to stop?

Alberto Gajofatto, Maria Donata Benedetti

World J Clin Cases. 2015 Jul 16; 3(7): 545–555.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517331/

■ The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review